LYCOS RETRIEVER 
Baxter Healthcare Corporation
built 253 days ago
Baxter Healthcare Corporation is the principal U.S. operating subsidiary of Baxter International Inc. (NYSE: BAX). Baxter International Inc., through its subsidiaries, assists healthcare professionals and their patients with treatment of complex medical conditions, including cancer, hemophilia, immune disorders, kidney disease and trauma. The company applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives. For more information about Baxter, please visit http://www.baxter.com .
Source:
Baxter Healthcare Corporation is the principal U.S. operating subsidiary of Baxter International Inc. (NYSE: BAX). Baxter International Inc., through its subsidiaries, assists healthcare professionals and their patients with the treatment of complex medical conditions, including hemophilia, immune disorders, cancer, infectious diseases, kidney disease, trauma and other conditions. The company applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives.
Source:
DEERFIELD, Ill., Nov. 9 /PRNewswire-FirstCall/ -- Baxter Healthcare Corporation today announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its V-Link Luer-activated device (LAD) with VitalShield protective coating. V-Link with VitalShield is the first needleless IV connector containing an antimicrobial coating. This new device has been shown to kill 99.9 percent of specific common pathogens (infection- causing microorganisms) known to cause catheter-related blood stream infections, including the highly treatment-resistant bacteria called methicillin-resistant Staphylococcus aureus, or MRSA. The Centers for Disease Control and Prevention (CDC) recently reported that MRSA infections cause an estimated 18,650 deaths per year in the United States (U.S.), which is more deaths in the U.S. per year than HIV/AIDS.
Source:
DEERFIELD, Ill., January 25, 2008 – Baxter Healthcare Corporation has announced the voluntary recall of nine lots of heparin sodium injection 1000 units/mL 10mL and 30mL multi-dose vials. The company began recalling the lots on January 17, 2008 as a precautionary measure due to an increase in the number of reports of adverse patient reactions that may be associated with the product. Baxter is conducting a thorough investigation of these reports to identify the cause of the increase in allergic-type reactions.
Source:
In 2001, Baxter Healthcare Corporation, a worldwide leader in the manufacture of global medical products, was concerned that its environmental footprint per unit output, a key benchmark of efficiency, was growing. To combat this, the company adopted a host of business and manufacturing methods. One worked: Lean Manufacturing. As Baxter began to see waste generation drop with the deployment of Lean, the environmental engineering group realized that environmental improvement was often an unintended benefit of Lean Manufacturing. In order to maximize this benefit, this group began to seek ways to further integrate environmental metrics and performance into traditional Lean Manufacturing tools.
Source:
Baxter Healthcare Corporation provides critical therapies for people with life-threatening conditions. Baxter is a leading manufacturer of plasma-based and recombinant proteins used to manage hemophilia. Other biopharmaceutical products include plasma-based therapies to manage immune disorders, alpha-1 antitrypsin deficiency and other chronic blood-related conditions; biosurgery products for hemostasis, wound-sealing, and tissue regeneration; and vaccines. Baxter ... is a leading manufacturer of manual and automated blood and blood-component separation and collection systems.
Source:
MORE ABOUT
Baxter Healthcare Corporation